HUM's CenterWell venture with BlackRock brings $2.8 billion in capital, easing balance sheet liabilities and supporting clinic expansion.
Humana (HUM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Humana's 2027 Medicare Advantage ratings rebound puts 95% of members in four-star or better plans, potentially boosting 2028 bonus payments and plan benefits.
| Health Care Providers & Services Industry | Healthcare Sector | James A. Rechtin CEO | XETRA Exchange | US4448591028 ISIN |
| US Country | 67,060 Employees | 30 Oct 2026 Last Dividend | 1 Aug 1991 Last Split | 22 Jan 1993 IPO Date |
Humana Inc., with its array of subsidiaries, stands as a major provider of medical and specialty insurance products across the United States. Initially established in 1961 and undergoing a name change from Extendicare Inc. to Humana Inc. in April 1974, the company is ingrained in the fabric of U.S. healthcare, having its roots and headquarters in Louisville, Kentucky. The organization operates through two primary segments: Insurance and CenterWell, showcasing a broad spectrum of health-related services and insurance products. Its purpose is deeply intertwined with offering extensive insurance coverage and healthcare services, primarily targeting individuals, employee groups, and military personnel.
Humana Inc.’s range of products and services underscores its commitment to providing comprehensive healthcare and insurance solutions. Here is a breakdown of its key offerings: